CSI Market
Sign In | Register

Strata Skin Sciences Inc (SSKN) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access SSKN Annual Cash Flow →
This page allows investors to follow Strata Skin Sciences Inc's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Sep 30 2025) (Jun 30 2025) (Mar 31 2025) (Dec 31 2024)
Operating Activities
Income-6.26
Depreciation & amortization4.12
Amortization of Other Assets1.20
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.13
Increase (Decrease) in Inventories0.29
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-0.09
Share-based Compensation0.64
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt1.14
Bad Debt Expense-
Noncash Interest Expense-
Write Off Of Deferred Debt Issuance Cost-
Write Off Of Unamortized Loan Costs-
Provision For Inventory Reserve-
Conversion Of Convertible Preferred Stock Into Common Stock-
Conversion Of Senior Secured Convertible Debentures Into Common Stock-
Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss-
Gain Loss On Cancelation Of Distributor Rights Agreement-
Impairment Of Lasers Placed In Service-
Increase Decrease In Operating Lease Liabilities-
Gain Loss On Forgiveness Of Debt-
Increase Decrease In Contract With Customer Liability0.20
Increase Decrease In Operating Lease Liability-0.25
Increase Decrease In Operating Lease Liability-
Increase Decrease In Operating Lease Liability-
Increase Decrease In Operating Lease Liability-
Settlement Gain with Supplier-0.68
Amortization Of Debt Issuance Costs And Debt Discount Premium0.12
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-1.00
Increase (Decrease) in Accounts Payable0.35
Increase (Decrease) in Other Accrued Liabilities-1.25
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.25
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-2.31
Discontinued operations0.00
Net Cash flow from Operating Activities-2.79
Investing Activities
Capital Expenditures-1.47
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Lasers Placedinservice Net-
Payment For Lasers Placed In Service Net-
Business Acquisition Reimbursement Of Purchase Price-
Payments For Distributor Rights Liability-
Assumed Deferred Revenue-
Assumed Deferred Revenue-
Assumed Deferred Revenue-
Assumed Deferred Revenue-
Assumed Deferred Revenue-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-1.47
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock3.58
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments For Borrowings And Warrant Exercises-
Payment Of Long Term Debt Expense-
Payments Fo Rborrowings And Warrant Exercises-
Proceeds From Committed Equity Financing Facility-
Proceeds From Exercise Of Stock Warrants-
Advance Fees Related To Equity Offering-
Advance Fees Related To Equity Financing-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents8.60
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities3.58
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-4.26
Total Cash Flow-0.68
4 historic quarters locked

Sign in to unlock the full Strata Skin Sciences Inc cash flow history.

Sign In Create Free Account

About Strata Skin Sciences Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001140361-25-042373

Figures are derived from filed reports and may be restated. Historical data is subject to revision.